Eye Infection Treatment Market Size and Overview
Loss of vision has been among the longstanding concerns for the medical world as well as governments. However, around 80% of the blindness cases are preventable and/or treatable. As underlined by FMI’s newly published research study, the global eye infection treatment market will register around US$ 10 Bn towards the end of forecast period, 2020-2030. Geriatric cohort is highly susceptible to eye infection, and requires greater medical attention. With ophthalmic problems arising with the age, elderly typically have to increase their visits to ophthalmologists. This remains the key factor driving demand for eye infection treatment.
Eye Infection Treatment Market - Key Research Findings
- The global eye infection treatment market was valued at about US$ 6.8 Bn in 2020.
- Antibiotics segment is expected to remain as the most preferred drug class segment in the eye infection treatment market.
- Growth of this segment is primarily attributed to growing prevalence of bacterial eye infections and increasing ocular surgical conditions.
- North America is stipulated to account for over a third of eye infection treatment market revenue by 2030.
- The North America market continues to offer lucrative opportunities for eye infection therapeutic manufacturers, owing to high risk of infections from increasing contact lenses use, and technology advancements in early diagnosis and treatment.
- Hospitals pharmacies will continue to be as prominent distribution channel in eye infection treatment market.
- Antibiotics and corticosteroids are expected to witness relatively high demand in public and private hospital pharmacies, owing to their use as primary drugs for effective treatment of eye infections.
- As such, expanding patient pool in hospital pharmacies owing to higher number of eye procedures are anticipated to drive the market for eye infections treatment, globally.
Key Factors Shaping the Eye Infection Treatment Market
Covid-19 Crisis Impact - Significant Delays and Rescheduling of Diagnosis and Treatment
The coronavirus (COVID-19) pandemic has set forth significant operational and economic challenges. Also, considerable time is needed for development and commercialization of effective treatment options for new pathogen of COVID-19. This uncertainty is expected to delay and reschedule the diagnosis and treatment of eye infection for coming two to three quarters. The eye infection treatment market is expected to gain pre-pandemic market demand during the first quarter of 2021, owing to availability of treatment and recovery of developed and emerging economies from COVID-19 pandemic. In addition, local government redirection of healthcare resources towards COVID-19 pandemic situation is also expected to engage most of healthcare workers to tackle the COVID-19 situation. This is also expected to slow down the market growth for short term.
High Prevalence of Eye Infection
Eye infections incidences are expected to rise globally. Emergence of new pathogens, increasing number of post-operative eye infections and poor eye hygiene practices are responsible for increasing eye infections worldwide. For instance, the National Ambulatory Medical Care Survey indicated that Americans made over 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis consult primary and urgent care providers, accounting for 1% of overall primary care office visits. Adenoviruses account for 65-90% of cases of viral conjunctivitis. In addition, global incidence of herpes simplex keratitis was calculated at approximately 1.5 million with 40, 000 new cases of severe monocular visual impairment or blindness a year.
Technology Advancements Aiding in Early Diagnosis and Treatment
Leading diagnostic industry players are focusing on development and commercialization of rapid point-of-care diagnostic technologies for eye infections. This rapid diagnosis is expected to boost accurate usage of anti-infective therapeutics. For instance, AdenoPlus is a single use, point-of-care diagnostic test for adenoviral conjunctivitis. AdenoPlus test is commercialized by Rapid Pathogen Screening and received CE mark in June 2011. The test is cheaper compared to current gold standard PCR test and is expected to accelerate early diagnosis and treatment for viral eye infections.
Eye Infection Treatment Market Structure Analysis
- The global eye infection treatment market is a fairly consolidated market. Approximately 50% share of the market is held by leading market players.
- In high-impact markets such as the US and Europe, there are more stringent regulations for approval of eye infection treatment products. Moreover, approval of eye infection treatment products for medical use is needed to fulfil the safety and efficacy requisites through clinical trials, and regulatory submission.
- Continuously rising R&D funding by leading players in development and launch of highly effective and safer eye infection treatments has led to greater availability of highly effective anti-infective products. Such new developments are boosting the growth of eye infection treatment market.
- Some of the major players in eye infection treatment market are the Pfizer Inc., Allergan, Plc. Alcon Laboratories, Inc., Akron Pharma Inc., and Bausch Health Companies Inc.
- Global eye infection treatment market players are also focused on emerging markets such as China, Brazil, and India, thanks to their strategic marketing network. Moreover, driven by significant partnerships and tie-ups with independent third-party sales organizations and presence of international global offices in other geographies, major manufacturers are able to deliver their product offerings efficiently.
Base year considered
Actual estimates/ Historical data
2015 - 2019
2020 - 2030
Value (USD) Mn
Drug Class, Dosage Form, Indication, Causative Agent, Distribution Channel, and Region
North America (US & Canada), Europe (UK, Germany, France, Spain, Italy, Russia, and Rest of Europe), Latin America (Brazil, Mexico, Argentina and Rest of LA), East Asia (China, Japan and South Korea) South Asia (India, Thailand, Indonesia, Malaysia, and Rest of SA), Oceania (Australia, and New Zealand), and MEA (GCC Countries, South Africa, Turkey, Northern Africa and Rest of MEA)
Pfizer Inc., Allergan, Plc., Alcon Laboratories, Inc., Akron Pharma Inc., Bausch Health Companies Inc., and Others
Major 20 players covered.
Revenue forecast, Covid-19 impact, company share, competitive landscape, growth factors, and trends
Eye Infection Treatment Market Analysis by Drug Class
Antibiotics continue to remain the preferred drug class, owing to rising caseloads of bacterial eye infection, as well as infection due to ocular drug delivery system. Given their efficacy in eye infection treatment, antibiotics are witnessing adoption upsurge in private and public hospital pharmacies. By 2022, market players would reap over US$ 4 Bn from antibiotics. Corticosteroids are also gaining traction in eye infection treatment. However, they are associated with side effects, including temporary and mild blurred vision.
Eye Infection Treatment Market Regional Insights
North America’s market is characterized by strong presence of prominent players. The region continues to gain the first-mover advantage in terms of tech-enabled advances in early diagnosis and eye infection treatment. Government, especially in the US, are organizing several campaigns to spread awareness regarding ophthalmic disorders and augmenting investments in ophthalmic diagnostic equipment. Further, increasing risk of infections driven by rising dependence on contact lenses is supplementing the prospects of eye infection treatment market in North America. The study reveals that North America would generate over 40% total returns to shareholders (TRS) through 2030.
Governments’ Role Crucial
In light of the rise in eye infection cases, Who and other international organizations maintain their focus on raising awareness. Efforts in diagnosis and eye infection treatment are ramping up. Case in point, VISION 2020 has been established with the aim to integrate a comprehensive, sustainable, and top-notch eye care system into national healthcare infrastructure. Such initiatives are highly beneficial for countries such as India, where cataract surgeries are performed for free via government programs, aiming to cover untapped sections of the society.
Antibiotics hold a prominent market share
Corticosteroids to exhibit a noteworthy CAGR
Eye drops remain highly preferred
Ophthalmic ointment to gain steady traction
Conjunctivitis remains top infection indication
Treatment rate for blepharitis to rise
Hospital pharmacies capture leading revenue share
Retail pharmacies to generate stable revenue
How Growth will Unfold
Hospital and retail pharmacies continue to shape revenue growth of eye infection treatment market. About 8 out of 10 drugs associated with eye infection treatment are distributed via both these channels. FMI states that, the trend would persist over the decade ahead. Market players are also uncovering new revenue lines in drug stores and online pharmacies, which would collectively register about US$ 3 Bn revenue in 2030. Nevertheless, players would stay glued to hospital and retail pharmacies for outsized returns.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
A recent market study published by Future Market Insights on the eye infection treatment market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics and Covid-19 crisis impact analysis. After conducting a thorough research on the historical as well as current growth parameters of the market, the growth prospects of the market are obtained with maximum precision.
Eye Infections Treatment Market Taxonomy
The global eye infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Ophthalmic Ointment
- Eye Drops
- Stye or Sty (Hordeolum)
- Ocular herpes
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
The report initiates with the executive summary of the eye infection treatment market, which includes a summary of key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the market.
Readers can find the definition and a detailed segmentation of the market in this chapter, which will help them understand the basic information about the market. Along with this, comprehensive information pertaining to types of products and their features are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the market report.
Eye infection treatment market report provides the key market trends that are expected to significantly impact market growth during the forecast period. Detailed industry trends are provided in this section.
This section includes the key successful factors and strategies being adopted by key market participants.
This section explains the global market value analysis and forecast for the market during the forecast period. This chapter includes a detailed analysis of the historical market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020-2030).
This chapter gives information about COVID-19 crisis impact analysis which comprises of current covid19 statistics and probable future impact, impact on GDP of individual key countries, segment wise impact, quarter-wise forecast and projected recovery quarter. In addition, this chapter includes drivers and restraints of the market. This section also includes macroeconomic factors and various opportunities of the market.
Based on drug class, the market is segmented into antibiotics, antivirals, antifungals, antihistamines, corticosteroids, and glucocorticoids. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on drug class.
Based on dosage form, the market is segmented into tablet, capsule, ophthalmic ointment, and eye drops. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on dosage form.
Based on indication, the market is segmented into conjunctivitis, keratitis, endophthalmitis, blepharitis, stye or sty (hordeolum), uveitis, cellulitis, and ocular herpes. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on indication.
Based on causative agents, the market is segmented into virus, bacteria, fungus, and allergens. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on causative agents.
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on distribution channel.
This chapter explains how the eye infection treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the drug class, dosage form, indication, causative agent, distribution channel, and countries in North America.
This chapter provides the growth scenario of the market in Latin American countries such as Brazil, Mexico, Argentina and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Important growth prospects of the market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Russia and the Rest of Europe are included in this chapter.
Important growth prospects of the eye infection treatment market across target segments in several countries such as China, Japan and South Korea are included in this chapter.
In this chapter, India and Indonesia countries are the prominent countries in the South Asia region. Readers can find detailed information about the growth parameters of the South Asia market during the forecast period of 2020-2030.
In this chapter, Australia and New Zealand are the prominent countries in the Oceania region. Readers can find detailed information about the growth parameters of the South Asia market during the forecast period of 2020-2030.
This chapter provides information about how the eye infection treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2020-2030.
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in market.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured are Pfizer Inc. (U. S.), Allergan Plc. (Ireland), Alcon Laboratories, Inc. (Switzerland), Akron Pharma Inc. (U. S.), Bausch Health Companies Inc. (Canada), Sanofi S.A. (France), Teva Pharmaceutical Industries Ltd. (Israel), Mylan N.V. (U. S.), Aurobindo Pharma (India), Lupin Limited (India), and Eyevance Pharmaceuticals LLC (U. S.).
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the eye infection treatment market report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the eye infection treatment market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Procurement Heads
- Sales Executives
- Raw Material Suppliers
- Industry Experts
- End Users
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Publications
- World Health Organizations (WHO)
- National Institute of Health (NIH)
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
- Trade Websites
Primary Interview Splits